After flooding, power outage in Rhode Island, CVS/pharmacy up and running
WOONSOCKET, R.I. CVS/pharmacy has restored the pharmacy computer system in its stores after massive flooding in Rhode Island caused a national computer system outage that impacted all of the chain’s 7,000 pharmacies.
CVS spokesperson Mike DeAngelis told Drug Store News that service was restored to its pharmacies Tuesday evening between 6 p.m. and 7:30 p.m.
For the most part, stores were able to fill prescriptions, but they were unable to process the insurance claims. As a result, pharmacists were instructed to complete all prescription requests and keep records for insurance purposes.
The CVS headquarters in Woonsocket lost power mid afternoon. It was one of several office complexes affected by flooding problems at local power substations, according to a local news report. The power loss caused the widespread computer outage.
Study finds Victoza more effective in treating Type 2 diabetes than competitor
PRINCETON, N.J. A study published online in the journal Diabetes Care indicated that a once-daily diabetes drug made by Novo Nordisk “further improves” blood sugar control and weight loss when patients switch to it from a competitor made by Eli Lilly, Novo Nordisk announced Tuesday.
The study, conducted by the Danish drug maker, was a 26-week study in Type 2 diabetes patients taking Novo Nordisk’s Victoza (liraglutide) or Lilly’s twice-daily Byetta (exenatide). The drugs are the only glucagon-like peptide-1, or GLP-1 agonists available on the market.
“Clinical benefits were seen in patients who switched from exenatide to Victoza,” University of North Carolina School of Medicine Diabetes Care Center director and study investigator John Buse said. “The significant improvements in blood sugar lowering and fasting glucose confirm the original findings of the trial regarding the efficacy of Victoza.”
Hospira completes Orchid acquisition
LAKE FOREST, Ill. Hospira has completed its $400 million acquisition of the generic injectables business of Orchid Chemicals & Pharmaceuticals, the generic drug maker announced Tuesday.
“We are excited to acquire new capabilities that will create opportunities for commercial growth, position us strongly in a key antibiotics product area, expand our global footprint and enhance our ability to provide lower-cost, high-quality products to patients,” Hospira COO Terry Kearney said. “We’re also excited to welcome a talented base of 450 employees, including newly appointed managing director [for] Hospira India, Dr. C.B. Rao, who joins us with a wealth of diversified industrial and management experience, and will provide continuity of leadership for the Orchid team joining Hospira.”
The acquisition, announced in February, includes Orchid’s beta-lactam antibiotic formuatlions manufacturing complex — comprising penicillin, cephalosporin and carbapenem facilities — and a pharmaceutical research and development facility in Irungattukottai, Chennai.